Giuseppe Ciaramella - 17 Dec 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: President
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol: BEAM
Transactions as of: 17 Dec 2024
Net transactions value: +$35,845
Form type: 4
Filing time: 19 Dec 2024, 16:10:03 UTC
Previous filing: 08 Nov 2024
Next filing: 03 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAM	Common Stock	Options Exercise	$35,845	+53,500	+49%	$0.6700	162,650	17 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BEAM	Stock Option (Right to Buy)	Options Exercise	$0	-53,500	-89%	$0.000000	6,505	17 Dec 2024	Common Stock	53,500	$0.6700	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this stock option vested 25% on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter.